LeMaitre Vascular, Inc. (LMAT)
81.55
-1.36
(-1.64%)
USD |
NASDAQ |
Oct 13, 16:00
81.55
0.00 (0.00%)
After-Hours: 20:00
LeMaitre Vascular Enterprise Value : 1.679B for Oct. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 13, 2026 | 1.679B |
| October 12, 2026 | 1.710B |
| October 09, 2026 | 1.659B |
| October 08, 2026 | 1.635B |
| October 07, 2026 | 1.627B |
| October 06, 2026 | 1.621B |
| October 05, 2026 | 1.666B |
| October 02, 2026 | 1.619B |
| October 01, 2026 | 1.648B |
| September 30, 2026 | 1.702B |
| September 29, 2026 | 1.709B |
| September 28, 2026 | 1.697B |
| September 25, 2026 | 1.678B |
| September 24, 2026 | 1.662B |
| September 23, 2026 | 1.656B |
| September 22, 2026 | 1.666B |
| September 21, 2026 | 1.625B |
| September 18, 2026 | 1.617B |
| September 17, 2026 | 1.631B |
| September 16, 2026 | 1.652B |
| September 15, 2026 | 1.649B |
| September 14, 2026 | 1.661B |
| September 11, 2026 | 1.657B |
| September 10, 2026 | 1.616B |
| September 09, 2026 | 1.631B |
| Date | Value |
|---|---|
| September 08, 2026 | 1.634B |
| September 04, 2026 | 1.659B |
| September 03, 2026 | 1.654B |
| September 02, 2026 | 1.683B |
| September 01, 2026 | 1.668B |
| August 31, 2026 | 1.650B |
| August 28, 2026 | 1.653B |
| August 27, 2026 | 1.636B |
| August 26, 2026 | 1.634B |
| August 25, 2026 | 1.620B |
| August 24, 2026 | 1.642B |
| August 21, 2026 | 1.686B |
| August 20, 2026 | 1.696B |
| August 19, 2026 | 1.732B |
| August 18, 2026 | 1.678B |
| August 17, 2026 | 1.701B |
| August 14, 2026 | 1.698B |
| August 13, 2026 | 1.687B |
| August 12, 2026 | 1.692B |
| August 11, 2026 | 1.708B |
| August 10, 2026 | 1.670B |
| August 07, 2026 | 1.676B |
| August 06, 2026 | 1.662B |
| August 05, 2026 | 1.620B |
| August 04, 2026 | 2.233B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp. | 74.87B |
| Abbott Laboratories | 205.21B |
| AngioDynamics, Inc. | 439.19M |
| Alphatec Holdings, Inc. | 2.161B |
| AtriCure, Inc. | 2.799B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 17.05M |
| Revenue (Quarterly) | 70.38M |
| Total Expenses (Quarterly) | 53.33M |
| EPS Diluted (Quarterly) | 0.695 |
| Gross Profit Margin (Quarterly) | 70.12% |
| Profit Margin (Quarterly) | 24.22% |
| Earnings Yield | 3.44% |
| Operating Earnings Yield | 4.00% |
| Normalized Earnings Yield | 3.442 |